SAREPTA THERAPEUTICS, INC. Zu einer Liste hinzufügen
|
Realtime-Estimate
Andere Börsenplätze
|
% 5 Tage | % 1. Jan. | ||
| 124,34 USD | -0,24 % |
|
-2,64 % | +28,93 % |
Hauptkonkurrenten
Zu einer Liste hinzufügen 0 ausgewählt | Umsatz ($) (Y-1) | Nettomarge (Y-1) | Umsatzrendite (Y-1) | ROE (Y-1) | ROA (Y-1) | Verschuldungsgrad (Verbindlichkeiten / EBITDA) (Y-1) | |
|---|---|---|---|---|---|---|---|
| 1,24 Mrd. | -43,11% | -21,54% | -86,15% | -1,86% | 1.96x | ||
| 9,87 Mrd. | +36,68% | +44,33% | +22,99% | +17,71% | -2.46x | ||
| 13,12 Mrd. | +30,14% | +39,08% | +20,74% | +16,20% | -1.6x | ||
| 1,3 Mrd. | -23,26% | -33,51% | -8,54% | -7,69% | 10.14x | ||
| 4,23 Mrd. | +24,36% | +18,08% | +4,62% | +4,02% | -13.1x | ||
| 2,46 Mrd. | -35,86% | -49,12% | -22,26% | -14,47% | 2.05x | ||
| 2,45 Mrd. | +26,42% | +32,30% | +14,78% | +13,31% | -5.01x | ||
| 5,69 Mrd. | +26,50% | +29,43% | +18,99% | +15,45% | -0.64x | ||
| 305 Mio. | -245,59% | -232,51% | - | -50,20% | -0.8x | ||
| 1,89 Mrd. | +13,23% | +13,30% | +12,68% | +8,89% | -5.76x | ||
| 50,93 Mio. | -205,30% | -166,94% | -58,43% | - | 2.98x | ||
| 285 Mio. | -181,75% | -144,69% | -51,94% | -32,60% | 2.5x | ||
| 829 Mio. | +33,96% | +40,71% | +293,15% | +20,80% | 2.73x | ||
| 1,83 Mrd. | +11,35% | +9,34% | +8,74% | +6,91% | -5.06x | ||
| 160 Mio. | -12,22% | -37,48% | -3,46% | -2,93% | 11.91x | ||
| 638 Mio. | +44,81% | +45,26% | +55,36% | +27,64% | 0.65x | ||
| Durchschnitt | 2,9 Mrd. | -31,23 % | -25,87 % | +14,75 % | +1,41 % | 0,03x | |
| Gewichteter Durchschnitt nach Marktkapitalisierung | 7,3 Mrd. | +4,09 % | +9,46 % | +14,22 % | +8,61 % | -1,22x |
- Börse
- Aktien
- A1J1BH Aktie
- Sektor Sarepta Therapeutics, Inc.
- Finanzielle Vergleiche
MarketScreener is also available in this country: United States.
Switch edition
Bei der aktuellen länderspezifischen Edition bleiben